Stockholm, Sweden

Anders Rudolf Hallberg

This inventor holds 9 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Vicore Pharma Ab, Labwell Ab, Personal Chemistry I Uppsala Ab. Active years: 2000-2026.

USPTO Granted Patents = 9 

% Patents Active = 44.4


 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 29(Granted Patents)


Location History:

  • Stockholm, SE (2010 - 2012)
  • Uppsala, SE (2000 - 2013)

Company Filing History:


Years Active: 2000-2026

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Anders Rudolf Hallberg

Introduction

Anders Rudolf Hallberg is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various medical conditions. With a total of 9 patents to his name, Hallberg's work has the potential to impact the treatment of autoimmune and fibrotic diseases.

Latest Patents

Among his latest patents are the "Selective angiotensin II compounds," which provide pharmaceutical compounds useful in treating autoimmune and fibrotic diseases, including interstitial lung diseases such as idiopathic pulmonary fibrosis and sarcoidosis. Another significant patent is for "Bicyclic angiotensin II agonists," which describes compounds that serve as selective agonists of the AT2 receptor. These compounds are particularly useful in treating gastrointestinal conditions like dyspepsia, IBS, and MOF, as well as cardiovascular disorders.

Career Highlights

Throughout his career, Hallberg has worked with several prominent companies, including Vicore Pharma AB and Labwell AB. His expertise in pharmaceutical development has allowed him to contribute to innovative solutions in the medical field.

Collaborations

Hallberg has collaborated with notable professionals in his field, including Mathias Alterman and Mats Larhed. These partnerships have further enhanced his research and development efforts.

Conclusion

Anders Rudolf Hallberg's contributions to pharmaceutical innovation are noteworthy, with a focus on developing compounds that address critical health issues. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…